.png?width=500&height=162&name=Generis%20Logo%20(2).png "Generis Logo (2)")
Recent Posts
In a recent study conducted for Pilgrim, quality and compliance professionals from the top 2,000 Pharmaceutical,...
The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle For years, pharmaceutical manufacturers...
Pharmaceutical technical writers are a broad collection of technical people including engineers, biologics, chemists,...
Biopharma M&A activity has already been big news in 2018. On January 22, it was reported that Celgene had bought the...
Last year, at the American Biomanufacturing Summit, we sat down with some thought leaders from MedImmune, AstraZeneca,...
Last year, at the American Biomanufacturing Summit, we sat down with some of our thought leaders to ask them where they...
In your experience, what has the outcome been like when an organization has taken the time to improve its’ single-use...
Many biopharmaceutical manufacturers are Implementing single-use containment and transfer of media and buffer materials...
Protein-based therapeutics, specifically monoclonal antibodies (mAbs), have become the focus of pharmaceutical R&D over...
This article first appeared in BioPharm International, October 1, Caroline Hroncich